Immune thrombocytopenia (ITP) trials in Australia
6 of 6 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Where
- Concord, Garran, Kogarah, Liverpool, Melbourne, Murdoch, Westmead, West Perth
- Age
- 18 years and over
- People
- 171 worldwide
- Run by
- Takeda
See details and how to joinNCT06722235 · EU 2024-514401-54-00 - Phase 3Taking peopleA Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Where
- Concord, Garran, Kogarah, Liverpool, Melbourne, Murdoch, Westmead, West Perth
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Takeda
See details and how to joinNCT06948318 · EU 2025-521692-31-00 - Phase 2Taking peopleStudy to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
- Where
- Box Hill, Clayton, Darlinghurst, Douglas, Melbourne, Woolloongabba
- Age
- 18 years and over
- People
- 56 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07104565 · EU 2025-521286-27-00 - Phase 1Taking peopleOM336 in Autoimmune Cytopenias
- Where
- Brisbane, Canberra, Sydney
- Age
- 18 years to 75 years
- People
- 32 worldwide
- Run by
- Lakefront Biotherapeutics West LLC
See details and how to joinNCT07083960 - Phase 1Taking peoplePhase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Where
- Camperdown, Melbourne, Sydney
- Age
- 18 years to 85 years
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06371417 · EU 2023-507692-21-00 - Phase 1Enrolling by invitationPhase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
- Where
- Camperdown, Melbourne, Sydney
- Age
- 18 years to 85 years
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06723106